FDA authorizes AstraZeneca COVID antibody treatment for emergency use
December 09, 2021 at 12:55 PM EST
The U.S. Food and Drug Administration on Wednesday issued emergency use authorization for AstraZeneca's Evusheld.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|